The extraction, isolation and purification of an endogenous regulator for the 5-HT2 receptor.

Pharmacol Res

Clinical Brain Disorders Branch, GCAP, NIMH, NIH, Building 10, CRC 7-3342, 10 Center Dr., Bethesda, MD 20892, United States.

Published: October 2011

Early studies indicated that serotonin, a primary transmitter in the central nervous system, may not represent the primary endogenous regulator for the 5-HT2 receptor labeled by [3H]-ketanserin. Instead, an endogenous ligand may be responsible for modulating the [3H]-ketanserin site. Through different isolation and purification procedures, a pronase-sensitive peptide with activity on [3H]-ketanserin binding was identified in the rat brain. This peptide seems specific for the 5-HT2 receptor since it does not displace the binding of [3H]-imipramine or [3H]-mianserin from rat cortical membranes and is able to stimulate PI turnover in a ketanserin sensitive fashion. Given the role of 5-HT2 receptors in the action of antidepressants, this finding may help understand some of the molecular mechanisms involved in antidepressant effect.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2011.05.022DOI Listing

Publication Analysis

Top Keywords

5-ht2 receptor
12
isolation purification
8
endogenous regulator
8
regulator 5-ht2
8
extraction isolation
4
purification endogenous
4
5-ht2
4
receptor early
4
early studies
4
studies indicated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!